返回 Agenda
[Session 4] Cardiovascular Safety in Oncology Drug Development: Mechanisms of Cardiotoxicity
Session Chair(s)
Katsuyoshi Chiba, PHD
Senior Director and Head, Group III, Medicinal Safety Research Laboratories, R&D, Daiichi Sankyo Co., Ltd., Japan
Atsushi Sugiyama, MD, PHD
Professor and Chairman, Department of Pharmacology, Toho University Faculty of Medicine, Japan
Speaker(s)
Atsuhiko T. Naito, MD, PHD
Associate Professor, Department of Pharmacology, School of Medicine, Toho University Faculty of Medicine, Japan
Drug-Induced Cardiac Toxicity: Translating Non-Clinical Observations into Early Clinical Investigation
Yasunari Kanda, PHD
Head of Division of Pharmacology, National Institute of Health Sciences, Japan
Development and Standardization of in vitro Contractility Method Using Human iPS Cell-Derived Cardiomyocytes
Junichi Ishida, MD, PHD
, The University of Tokyo Hospital, Japan
Molecular Pathways and Pathophysiology of TKI Induced Cardiotoxicity